Mean vector fecundity (blue) and fertility (orange) per treatment. by Blaženka D. Letinić (8442753)

“…<p><i>Akirin</i> knockdown mosquitoes had a reduced mean fecundity by 17–25% (one-way ANOVA: <i>p</i><0.01, F = 16.5, DF = 4), and a reduced mean fertility by 23–29% (one-way ANOVA: <i>p</i><0.01, F = 63.4, DF = 4), when compared to the control treatments. …”

Tau exon 10 alternative splicing and tauopathies-1 by Fei Liu (21082)

“…The first half of exon 10 has three exonic splicing enhancers (SC35-like, PPE and ACE). A central exon splicing silencer (ESS) separates the 5' ESE elements from a less characterized ESE at the 3'-end of exon 10. …”

The distribution of migratory microglial cells and the association between mRNA levels and the number of migrated microglial cells during retinal degeneration in RCS rats. by Yong Liu (6908)

“…(B) mRNA levels of MFG-E8 and integrin αυ showed more significant linear regression with the migration of microglial cells than the integrin β5. (C) mRNA level of CD11b was significantly associated with the migration of microglial cells and IL-1β and TNF-α showed a modestly linear regression, but the association between mRNA levels of MCP-1 and microglial cells was slightly negative, which might be owed to a dramatic reduction of apoptotic cells and a possible decrease in the phagocytic activity (or requirement) of microglial cells in the ONL.…”

Tau exon 10 alternative splicing and tauopathies-0 by Fei Liu (21082)

“…The first half of exon 10 has three exonic splicing enhancers (SC35-like, PPE and ACE). A central exon splicing silencer (ESS) separates the 5' ESE elements from a less characterized ESE at the 3'-end of exon 10. …”

Ultra-high performance pastes under pressure curing by Carolina Noda Livi (6826886)

“…They showed the influence of pressurizing on the development of a compact and homogeneous matrix, but with an increase in microporosity and a decrease in the amount of hydration products formed. …”

Prostaglandin E(PGE) does not affect total proteoglycan release by Elena V Tchetina (38723)

“…<p><b>Copyright information:</b></p><p>Taken from "Prostaglandin PGEat very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and , a gene linked to chondrocyte hypertrophy"</p><p>http://arthritis-research.com/content/9/4/R75</p><p>Arthritis Research & Therapy 2007;9(4):R75-R75.…”

Numerical Simulation of the Impact of Soil Mixing on Luminescence Age Distributions by Aimin Zhang (17679711)

Impact of combined oil-in-water emulsions and particulate suspensions on ceramic membrane fouling and permeability recovery by Abdalla M.

“…The addition of 1500 mg·L−1 of bentonite to a 10 vol.% emulsion resulted in a permeability decrease of 3.5–5 times over that recorded for the emulsion, and 8–36 times lower than that of the bentonite suspension. …”
Get full text
Get full text

Effect of the NTSR1 agonist and antagonist in AMY on CFS. by Hiroyuki Toda (564669)

“…<b><i>E</i></b>, Bilateral infusions of a NTSR1 agonist (PD149613) dissolved in 0.5 µl of saline into AMY produced a significant decrease in the freezing rate at a concentration of 100 µM at the second exposure (n = 7 – 8 rats per all groups; *<i>p</i><0.05 vs. saline or DMSO control). …”

Effect of ABCG2 overexpression on the expression of SLC transporter genes and MPP, glucose and glutamine transport. by Maricla Galetti (475203)

“…<p>Down-regulation of SLC transporter expression (SLC22A1, SLC22A3, SLC2A1, SLC38A2, SLC3A2, SLC7A5, and SLC7A6) in HEK293/R2 cells versus HEK293 was evaluated by PCR drug transporter array (A). …”

Image_2_Global Characterization of Peripheral B Cells in Parkinson’s Disease by Single-Cell RNA and BCR Sequencing.jpeg by Pingping Wang (1485592)

“…Finally, we found a marked clonal expanded memory B cell population in PD patients, up-regulating both MHC II genes (HLA-DRB5, HLA-DQA2 and HLA-DPB1) and transcription factor activator protein 1 (AP-1), suggesting that the antigen presentation capacity of B cells was enhanced and B cells were activated in PD patients. …”

Table_2_Global Characterization of Peripheral B Cells in Parkinson’s Disease by Single-Cell RNA and BCR Sequencing.xlsx by Pingping Wang (1485592)

“…Finally, we found a marked clonal expanded memory B cell population in PD patients, up-regulating both MHC II genes (HLA-DRB5, HLA-DQA2 and HLA-DPB1) and transcription factor activator protein 1 (AP-1), suggesting that the antigen presentation capacity of B cells was enhanced and B cells were activated in PD patients. …”

Image_1_Global Characterization of Peripheral B Cells in Parkinson’s Disease by Single-Cell RNA and BCR Sequencing.jpeg by Pingping Wang (1485592)

“…Finally, we found a marked clonal expanded memory B cell population in PD patients, up-regulating both MHC II genes (HLA-DRB5, HLA-DQA2 and HLA-DPB1) and transcription factor activator protein 1 (AP-1), suggesting that the antigen presentation capacity of B cells was enhanced and B cells were activated in PD patients. …”

Silencing BRE Expression in Human Umbilical Cord Perivascular (HUCPV) Progenitor Cells Accelerates Osteogenic and Chondrogenic Differentiation by Elve Chen (392737)

“…<i>BRE</i>-silencing negatively regulated <i>OCT4</i>, <i>FGF5</i> and <i>FOXO1A</i>. <i>BRE</i>-silencing also altered the expression of epigenetic genes and components of the TGF-β/BMP and FGF signaling pathways which are crucially involved in maintaining stem cell self-renewal. …”

Table_1_Global Characterization of Peripheral B Cells in Parkinson’s Disease by Single-Cell RNA and BCR Sequencing.xlsx by Pingping Wang (1485592)

“…Finally, we found a marked clonal expanded memory B cell population in PD patients, up-regulating both MHC II genes (HLA-DRB5, HLA-DQA2 and HLA-DPB1) and transcription factor activator protein 1 (AP-1), suggesting that the antigen presentation capacity of B cells was enhanced and B cells were activated in PD patients. …”

IPA analysis reveals oxidative phosphorylation pathway. by Claudia Kruger (141215)

“…HF <i>Acads+/+</i> mice, we found significantly decreased expression of ATP synthase genes in mitochondrial complex 5 (top panel), consistent with a state of decreased energy availability.…”

Image1_Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model.TIF by Ádám István Horváth (15443678)

“…Introduction<p>Monoiodoacetate (MIA)-induced osteoarthritis (OA) is the most commonly used rodent model for testing anti-OA drug candidates. Herein, we investigated the effects of our patented multitarget drug candidate SZV-1287 (3-(4,5-diphenyl-1,3-oxazol-2-yl) propanal oxime) that is currently under clinical development for neuropathic pain and characterized the mouse model through complex functional, in vivo imaging, and morphological techniques.…”

Table1_Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model.docx by Ádám István Horváth (15443678)

“…Introduction<p>Monoiodoacetate (MIA)-induced osteoarthritis (OA) is the most commonly used rodent model for testing anti-OA drug candidates. Herein, we investigated the effects of our patented multitarget drug candidate SZV-1287 (3-(4,5-diphenyl-1,3-oxazol-2-yl) propanal oxime) that is currently under clinical development for neuropathic pain and characterized the mouse model through complex functional, in vivo imaging, and morphological techniques.…”

Image3_Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model.TIF by Ádám István Horváth (15443678)

“…Introduction<p>Monoiodoacetate (MIA)-induced osteoarthritis (OA) is the most commonly used rodent model for testing anti-OA drug candidates. Herein, we investigated the effects of our patented multitarget drug candidate SZV-1287 (3-(4,5-diphenyl-1,3-oxazol-2-yl) propanal oxime) that is currently under clinical development for neuropathic pain and characterized the mouse model through complex functional, in vivo imaging, and morphological techniques.…”

Image2_Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model.TIF by Ádám István Horváth (15443678)

“…Introduction<p>Monoiodoacetate (MIA)-induced osteoarthritis (OA) is the most commonly used rodent model for testing anti-OA drug candidates. Herein, we investigated the effects of our patented multitarget drug candidate SZV-1287 (3-(4,5-diphenyl-1,3-oxazol-2-yl) propanal oxime) that is currently under clinical development for neuropathic pain and characterized the mouse model through complex functional, in vivo imaging, and morphological techniques.…”